Riskpilot← Back to searchSign inGet full accessRedwood Pharma AB
ABBankruptOrg 5568851280Research and experimental development on natural sciences and engineering · NACE 7210Est. 20120 employees
Revenue 2023
SEK 0
EBITDA margin
—
+1% vs 2022
Equity ratio
93.8%
Financial strength
Net profit 2023
SEK -14,2M
-9% vs 2022
| Revenue | SEK 0 | — |
| EBITDA | SEK -13M | +1% |
| Net profit | SEK -14,2M | -9% |
| Total assets | SEK 14,5M | -21% |
| Equity | SEK 13,6M | -11% |
| Employees | 0 | — |
Legal name
Redwood Pharma AB
Org number
5568851280
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
23 februari 2012
Share capital
SEK 13 269 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Aktiebolaget skall utveckla, producera och marknadsföra läkemedel samt idka därmed förenlig verksamhet.
Address
Email
martin.vidaeus@redwoodpharma.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −15 512 | −14 523 | −20 480 | −13 048 | −12 964 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −545 |
| EBIT | −15 512 | −14 523 | −20 480 | −13 048 | −13 509 |
| Net financials | −246 | −3 | −361 | 8 | −675 |
| Profit before tax | −15 758 | −14 525 | −20 841 | −13 040 | −14 185 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −15 758 | −14 525 | −20 841 | −13 040 | −14 185 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 14 418 | 12 847 | 21 217 | 18 217 | 14 478 |
| Equity | 12 151 | 7 080 | 15 894 | 15 304 | 13 585 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2 267 | 5 767 | 5 323 | 2 912 | 894 |
| Total debt | 2 267 | 5 767 | 5 323 | 2 912 | 894 |
EBITDA margin
-1296400000.0%
This company
15.8%
Market median
-8205063391% vs market
20192023
Equity ratio
93.8%
This company
38.2%
Market median
+146% vs market
20192023
Return on equity
-104.4%
This company
18.4%
Market median
-667% vs market
20192023
Net profit margin
-1418500000.0%
This company
8.1%
Market median
-17512345779% vs market
20192023
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20192023
Debt / equity
0.07×
This company
0.62×
Market median
+89% vs market
20192023
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
KR Audit | Audit | 2021 |
MO Chief Executive Officer | Chief Executive Officer | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Board of Directors | 2021 | |
| Board of Directors | 2021 | |
| Former (4) | ||
| Board of Directors | 2023 – 2023 | |
| Chairman | 2021 – 2022 | |
| Board of Directors | 2021 – 2022 | |
| Board of Directors | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Redwood Pharma AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karl Rasmus Mandel | Audit | 0 companies |
| Martin Olov Vidaeus | Chief Executive Officer | 0 companies |
| Olof Ulf Stefan Björklund | Chairman | 0 companies |
| Tom Juhani Rönnlund | Board of Directors | 0 companies |
| Claes Göran Mikael Eckerwall | Board of Directors | 0 companies |
| Nils Gunnar Mattsson | Chairman | 0 companies |
| Mats Olof Magnus Lidgard | Board of Directors | 0 companies |
| Hans Gunnar Ageland | Board of Directors | 0 companies |
| Mats Håkan Magnusson | Board of Directors | 0 companies |